Regeneron Pharmaceuticals, Inc. (REGN) Tops Q4 EPS by 36c
Tweet Send to a Friend
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of $1.47 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
